Concert Pharmaceuticals, Inc. announced that Christine van Heek has been appointed to its Board of Directors and will serve as a member of its audit committee effective April 8, 2016. Ms. van Heek has more than 30 years of experience in the healthcare and biotechnology industry, including 13 years at Genzyme Corporation where she held positions as President of the Therapeutics Division, General Manager of the Renal Division, and Vice President of Global Marketing. Ms. van Heek replaces Helmut M. Schühsler, Ph.D. who has resigned from company's Board of Directors.

Ms. van Heek has served as an advisor and consultant to several companies on global commercialization, sales, marketing and business development in the biotechnology and pharmaceutical industry. Ms. van Heek currently serves on the Board of Directors for Visioneering Technologies, Inc.